000 | 01610 a2200445 4500 | ||
---|---|---|---|
005 | 20250513161200.0 | ||
264 | 0 | _c19990129 | |
008 | 199901s 0 0 eng d | ||
022 | _a0028-8446 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMauger, D C | |
245 | 0 | 0 |
_aChildhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991. _h[electronic resource] |
260 |
_bThe New Zealand medical journal _cNov 1998 |
||
300 |
_a454-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aAsparaginase _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aCranial Irradiation |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
650 | 0 | 4 |
_aDaunorubicin _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aMercaptopurine _xadministration & dosage |
650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
650 | 0 | 4 | _aNew Zealand |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xdiagnosis |
650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRadiotherapy, Adjuvant |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
700 | 1 | _aSkeen, J E | |
773 | 0 |
_tThe New Zealand medical journal _gvol. 111 _gno. 1078 _gp. 454-6 |
|
999 |
_c9853323 _d9853323 |